- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Solid Malignancies in South Africa
Total 560 results
-
Turning Point Therapeutics, Inc.TerminatedNon-Small Cell Lung Cancer | NSCLC | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | ALK Gene MutationUnited States, Australia, Korea, Republic of
-
Silverback TherapeuticsActive, not recruitingHER2 Positive Solid TumorsUnited States, Korea, Republic of, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI); MedStar Georgetown University HospitalActive, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States, Canada
-
Supriya MohileNational Cancer Institute (NCI); University of Chicago; City of Hope National...CompletedLymphoma | Toxicity | Adult Solid NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | HER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Nested Therapeutics, IncRecruitingGlioma | Melanoma | NSCLC | Oncology | Solid Tumor, Adult | MEK Mutation | RAF Gene Mutation | Ras (KRAS or NRAS) Gene Mutation | MAPK Pathway Gene MutationUnited States, Australia
-
Impact Therapeutics, Inc.CompletedBreast Cancer | Ovarian Cancer | Prostate Cancer | Primary Peritoneal Cancer | Advanced Solid TumoursAustralia
-
Sonnet BioTherapeuticsHoffmann-La RocheRecruitingAdvanced Solid Tumor | Platinum-resistant Ovarian CancerUnited States, Australia
-
BeiGeneMyriad Genetics, Inc.CompletedLocally Advanced or Metastatic Solid TumorsSpain, Australia, United States, United Kingdom
-
National Cancer Institute (NCI)Children's Oncology GroupCompletedUnspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol Specific | NeurotoxicityUnited States, Canada, Australia, Switzerland
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Extensive Stage Small Cell Lung CancerUnited States
-
Novartis PharmaceuticalsCompletedSolid TumorsGermany, United States, Netherlands, Spain, Canada, Hong Kong, Italy, Singapore, Australia, Israel, Korea, Republic of, Taiwan, France, Norway, Thailand
-
Beijing InnoCare Pharma Tech Co., Ltd.RecruitingAdvanced Solid Tumors | Cholangiocarcinoma | Urothelial CarcinomaAustralia, United States
-
Keythera Pharmaceuticals (Australia) Pty LtdRecruitingGastric Cancer | Colorectal Cancer | Lung Cancer | Bladder Cancer | Advanced Solid Tumor | Squamous Cell Carcinoma of the EsophagusAustralia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Metastatic CancerUnited States
-
Molecular Templates, Inc.RecruitingSquamous Cell Carcinoma of Head and Neck | Advanced Solid Tumor | Non-small Cell Lung CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedAnorexia | Unspecified Adult Solid Tumor, Protocol Specific | CachexiaUnited States
-
FBD Biologics LimitedRecruitingAdvanced Solid Tumor | Refractory Non-Hodgkin LymphomaTaiwan, United States
-
University of Rochester NCORP Research BaseNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
AstraZenecaParexel; Iqvia Pty Ltd; Medidata Solutions; CISCRPActive, not recruitingSolid TumorSpain, United Kingdom, United States, Canada, Czechia, Poland, Romania, Thailand, Vietnam, Belgium, France, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Malaysia, Taiwan, Australia, Germany, Turkey, Ukraine, Nethe... and more
-
National Cancer Institute (NCI)Glaxosmithkline Biologicals S.A.TerminatedRenal Failure | Solid Neoplasm | BRAF Gene Mutation | Hepatic ComplicationUnited States, Canada
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedBrain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada, Australia
-
Kartos Therapeutics, Inc.GlaxoSmithKlineCompletedMelanoma | Cancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States, Australia
-
Abion IncNovotech (Australia) Pty LimitedRecruitingAdvanced Solid TumorsAustralia, Korea, Republic of
-
AbbVieGenentech, Inc.; AmgenTerminatedAcute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Diffuse Large B-cell LymphomaUnited States, Australia, Germany
-
Genentech, Inc.Chugai Pharmaceutical Co.RecruitingGastric Cancer | Metastatic Solid Tumor | Non-small Cell Lung Cancer | Pancreatic Ductal AdenocarcinomaKorea, Republic of, Spain, Japan, New Zealand, Australia, United States, Italy, Brazil
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPain | Unspecified Adult Solid Tumor, Protocol Specific | NeurotoxicityUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Dermatologic ComplicationsUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsUnited States, Canada, France, Taiwan, Belgium, Spain, Singapore, Italy, Australia, Hong Kong, Germany, Japan
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Weight ChangesUnited States
-
Mural Oncology, IncCompletedAdvanced Solid TumorsCanada, Spain, United States, Australia, Belgium, Korea, Republic of, Poland
-
Incyte Biosciences International SàrlCompletedMetastatic Cancer | Advanced MalignanciesUnited States, Belgium, Australia, Spain
-
AmgenRecruitingAdvanced MTAP-null Solid TumorsUnited States, Canada, Taiwan, Switzerland, United Kingdom, Korea, Republic of, Germany, Austria, France, Belgium, Australia, Hong Kong, Japan
-
Mural Oncology, IncCompletedAdvanced Solid TumorsKorea, Republic of, United States, Canada, Netherlands, Spain, Taiwan
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Locally Advanced Solid Tumor | Neoadjuvant Melanoma | Head and Neck Squamous Cell Carcinoma HNSCC | HPV-associated Cancers | Neoadjuvant Cutaneous Squamous Cell Carcinoma (cSCC)United States, Australia, Spain, Netherlands, Korea, Republic of, Taiwan
-
Dragonfly TherapeuticsMerck Sharp & Dohme LLCRecruiting
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, United States, Spain, France, Italy, Korea, Republic of, Poland
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Metastatic CancerUnited States
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Platinum-resistant Ovarian Cancer | Locally Advanced Solid Tumor | Post Anti-PD-1 Melanoma | 2L+ Cervical Cancer | Neoadjuvant Melanoma | Neoadjuvant Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Small Cell...United States, Australia, Korea, Republic of
-
University of RochesterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Dyspnea | Pulmonary ComplicationsUnited States
-
PlexxikonTerminatedAcute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Myelodysplastic Syndrome | Solid TumorsUnited States
-
ImmVira Pharma Co. LtdActive, not recruitingHepatocellular Carcinoma | Colorectal Cancer | Ovarian Cancer | NSCLC | Solid Tumor | Endometrial CancerUnited States
-
PlexxikonTerminatedSolid Tumor | Tenosynovial Giant Cell Tumor | Tumors of Any Histology With Activating Trk (NTRK) Point or NTRK Fusion MutationsUnited States
-
Boehringer IngelheimRecruitingLung Neoplasms | Pancreatic Neoplasms | Bladder Cancer | Solid Tumors | Biliary Tract CancerUnited States, Korea, Republic of, Spain, Australia, Japan, Germany, Taiwan, Singapore, Thailand, France, Belgium, Austria, Switzerland, United Kingdom, South Africa
-
Eli Lilly and CompanyActive, not recruitingRelapsed Solid Tumor | Refractory Solid TumorUnited States, Canada, France, Australia, Belgium, Germany, Spain, Italy
-
GlaxoSmithKlineTerminatedSolid TumoursUnited States, Spain, Australia, United Kingdom
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer | Neurotoxicity | Radiation Toxicity | Cognitive/Functional EffectsUnited States
-
BioMed Valley Discoveries, IncTerminatedAdvanced Solid Tumor | MAP2K1 Gene Mutation | BRAF Gene Mutation | MEK Mutation | BRAF Gene Alteration | MEK Alteration | MAP2K1 Gene Alteration | MAP2K2 Gene Mutation | MAP2K2 Gene AlterationUnited States
-
AbbVieActive, not recruitingAdvanced Solid TumorsUnited States, Australia, Canada, Israel, Japan, Korea, Republic of, Netherlands, Puerto Rico, Spain, Taiwan